Answers are grounded in this paper and cite their sources.
Case report demonstrates severe mucositis from methotrexate in an older woman, highlighting treatment challenges.
Intro Methotrexate is a commonly used medication for a variety of autoimmune diseases, including rheumatoid arthritis and psoriatic arthritis. It has several adverse effects with which clinicians are familiar, including GI upset, fatigue, B12 deficiency, immunosuppression. Oral ulcers/mucositis are a frequent complication of methotrexate that can be bothersome, however rarely it can cause more severe symptoms. Case A 66 year old woman with psoriatic arthritis on methotrexate was advised by her dermatologist to present to the hospital after she developed ulcers in her mouth, for concern of pemphigus vulgaris. She was admitted to Medicine initially and evaluated by dermatology, who recommended pulse dose steroids. However, the patient developed acute hypoxic respiratory failure with stridor, requiring intubation and transfer to MICU. She was re evaluated by dermatology as well as rheumatology, who decided that her presentation may actually be more consistent with methotrexate induced grade 4 mucositis. On further history, it turned out that the patient had only recently been diagnosed with psoriatic arthritis, and had just started methotrexate a few weeks before, receiving three doses of methotrexate. She was started on leucovorin for treatment of the methotrexate induced mucositis as well as Heliox to help aid her respiratory effort due to the airway narrowing. Palifermin was recommended but unavailable at our institution. GI performed an EGD with biopsy (which was later negative). Her airway status and mucositis gradually improved, and she was extubated after several days. She was eventually transferred to the floor, and discharged home with near resolution of her mucositis. Discussion This patient was fortunate to present to a multidisciplinary center where rheumatology and dermatology were available and able to implement a successful treatment plan. Her delay in treatment is likely due to the rareness of the degree of severity of her mucositis. This case serves as a reminder to clinicians to keep in mind the degree of severity of adverse effects of common medications used.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: